JAPAN'S EISAI TO SEEK US FDA APPROVAL OF BREAST CANCER DRUG.
Publication: AsiaPulse News
Publication Date: 31-MAY-06
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
TOKYO, May 31 Asia Pulse - Eisai Co. (TSE:4523) will apply to the U.S. Food & Drug Administration as early as this fiscal year for approval of a breast cancer drug.
The company plans to conduct phase I clinical trials in Japan beginning in June. If all goes well...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
